We have observed
11 EP applications
James Christopher Legg
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after August 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Methods of monitoring conditions by sequence analysis
BIOMARKERS OF CANCER
Nucleic acid quantitation from tissue slides
T-CELL RECEPTOR CLONOTYPES SHARED AMONG ANKYLOSING SPONDYLITIS PATIENTS
METHOD OF MEASURING IMMUNE ACTIVATION
DETECTION AND MEASUREMENT OF TISSUE-INFILTRATING LYMPHOCYTES
MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
NANOPORE BASED MOLECULAR DETECTION AND SEQUENCING
METHODS FOR CREATING BILAYERS FOR USE WITH NANOPORE SENSORS
POLYMERASE ENZYME SUBSTRATES WITH PROTEIN SHIELD
SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION